This 2010 CBS News feature explores the danger of bogus therapies using stem cells.
The Hertzberg Schechter awards committee unanimously approved Dr. Beatriz C.G. de Freitas for the prize, valued at $10,000, to support a research trip to the Weizmann Institute in Israel to engage in collaborative research and seed collaborative research for two to four weeks. Dr. Freitas is interested in modeling normal and affected early stages of human nervous system development using pluripotent stem cells, focusing on human astrocytes. (Image: [left to right] Richard Hertzberg; Sylvia M. Evans, PhD; Beatriz Freitas, PhD; Larry Goldstein, PhD)
The selection committee is seeking applicants who have an MD degree, are in a fellowship program at UC San Diego, have stem cell related research projects in mind, and have time available during their current fellowship to pursue them. Stipends are competitive, and recipients can perform up to 25% clinical service. Please email jbraswell "@" ucsd.edu for more info.
Larry Goldstein speaks at an event held by the California Healthcare Institute at the Salk Institute in July, 2013, covered by the San Diego Union-Tribune.
UC San Diego has appointed Professor Eric T. Ahrens, PhD, to the Faculty in Radiology. Eric Ahrens is the recipient of the California Institute for Regenerative Medicine's Research Leadership award. Dr. Ahrens was most recently a professor of biological sciences at Carnegie Mellon University, Pittsburgh. Dr. Ahrens will be located in the Sanford Consortium for Regenerative Medicine, where he will work collaboratively with stem cell researchers to develop advanced techniques to monitor cell location and fate after delivery to the body.
Larry Goldstein discussing stem cell research at TEDx in San Diego.
The University of California, San Diego, with nearly $985 million in annual research funding, plays a leading role in stem cell research to help develop cures and therapies for a wide range of diseases and disorders utilizing pluripotent stem cell research. Basic research is needed to use these cells to develop new therapies, and clinical translational research may bring our discoveries to patients in the clinic. In the years to come many people will have increased hope for their loved ones affected by a wide range of disorders because of the work of basic and physician scientists at UC San Diego and its partner institutions of the Sanford Consortium for Regenerative Medicine. UC San Diego is committed to collaborating with other research institutions to maximize resources, facilitate research, and accelerate understanding of human health and disease.
International Society for Stem Cell Research (Vancouver, Canada)
San Diego Festival of Science and Engineering
Stem Cell Meeting on the Mesa IX
The New York Stem Cell Foundation Annual Meeting